annual meeting program - American Society of Clinical Oncology

Clinical Trials in Survivorship Populations: Emerging Concepts and Barriers to
Application
Location: S100a
CME credit: 1.25
Track(s): Clinical Trials
Melissa M. Hudson, MD—Chair
St. Jude Children’s Research Hospital
Promoting Health during and beyond Cancer Therapy
Melinda L. Irwin, PhD, MPH
Yale University
Conducting Clinical Trials of Physical Activity in Cancer Survivors
Janette L. Vardy, MD, PhD
The University of Sydney
Clinical Trials in Cancer Survivors with Chemotherapy-related Cognitive Impairment
Curable and Highly Treatable Leukemias: How Do I Optimize Outcome?
Location: E354a
CME credit: 1.25
Track(s): Leukemia, Myelodysplasia, and Transplantation
Moshe Talpaz, MD—Chair
University of Michigan
Therapy for CML: What Is the Best TKI? When? And Beyond?
Bayard L. Powell, MD
Wake Forest University
Update on Acute Promyelocytic Leukemia
Giuseppe Saglio, MD
University of Turin
Monitoring Recommendations: What Defines Resistance?
How to Use Data to Improve Practice: Nexus of Quality and Efficiency
Location: E353
CME credit: 1.25
Track(s): Practice Management and Information Technology; Professional Development
Robert D. Siegel, MD—Chair
The Helen & Harry Gray Cancer Center
Getting More out of QOPI
Peter G. Ellis, MD
University of Pittsburgh Medical Center Cancer Center
Challenge of Reducing Disease-specific Variation in Care
Saturday, June 5, 2010
David C. Fryefield, MD
Willamette Valley Cancer Institute
Quality and Efficiency: Continuous Improvement Tools for the Oncology Practice
81
SATURDAY